Related Experiment Video
Updated: Jun 11, 2026

An In Vitro Approach to Photodynamic Therapy
Published on: August 17, 2018
Gallic acid induces apoptosis in A375.S2 human melanoma cells through caspase-dependent and -independent pathways
Chyi Lo1, Tung-Yuan Lai, Jen-Hung Yang
1School of Chinese Medicine, China Medical University, Taichung 404, Taiwan, ROC.
Abstract:
The natural antioxidant gallic acid (GA) has demonstrated a significant inhibition of cell proliferation and induction of apoptosis in a series of cancer cell lines. However, there is no available information to show whether GA induces apoptosis in human skin cancer cells. In the present study, we report GA-induced apoptosis in A375.S2 human melanoma cells. GA affected morphological changes, decreased the percentage of viable cells and induced apoptosis in A375.S2 cells in a dose- and time-dependent manner. Observation of the molecular mechanism of apoptosis in A375.S2 cells showed that GA up-regulated the proapoptotic proteins such as Bax, and induced caspase cascade activity, but down-regulated antiapoptotic proteins such as Bcl-2. GA induced reactive oxygen species (ROS) and intracellular Ca2+ productions and decreased the level of mitochondrial membrane potential (DeltaPsim) in A375.S2 cells in a time-dependent manner. GA triggered cytosolic release of apoptotic molecules, cytochrome c, promoted activation of caspase-9 and caspase-3, and ultimately apoptotic cell death. In addition, GA also promoted cytosolic release of apoptosis-inducing factor (AIF) and endonuclease G (Endo G). Therefore, GA may also induce apoptosis through a caspase-independent pathway. Our results suggest that GA might be a potential anticancer compound; however, in depth in vivo studies are needed to elucidate the exact mechanism.
Insights
Gallic acid (GA) induces apoptosis in human melanoma cells by altering cell viability and triggering key molecular pathways. Further in vivo studies are needed to confirm its potential as an anticancer compound.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Gallic acid (GA) is a natural antioxidant with known anticancer properties.
- Previous studies show GA inhibits proliferation and induces apoptosis in various cancer cell lines.
- The effect of GA on human skin cancer cells, specifically melanoma, remains largely uninvestigated.
Purpose of the Study:
- To investigate the induction of apoptosis by gallic acid (GA) in A375.S2 human melanoma cells.
- To elucidate the molecular mechanisms underlying GA-induced apoptosis in melanoma.
- To assess the potential of GA as an anticancer agent for skin cancer.
Main Methods:
- Treatment of A375.S2 human melanoma cells with varying doses and times of GA.
- Morphological assessment and viability assays.
- Analysis of apoptosis-related protein expression (Bax, Bcl-2) and caspase activity.
- Measurement of reactive oxygen species (ROS), intracellular calcium (Ca2+), and mitochondrial membrane potential (ΔΨm).
- Detection of apoptotic molecules (cytochrome c, AIF, Endo G) release.
Main Results:
- GA induced morphological changes, decreased cell viability, and promoted apoptosis in A375.S2 cells in a dose- and time-dependent manner.
- GA modulated the expression of proapoptotic (Bax) and antiapoptotic (Bcl-2) proteins, activating the caspase cascade.
- GA increased ROS and Ca2+ levels, decreased mitochondrial membrane potential, and triggered the release of cytochrome c, AIF, and Endo G.
Conclusions:
- Gallic acid induces apoptosis in human melanoma cells through both caspase-dependent and potentially caspase-independent pathways.
- GA affects key molecular players in apoptosis, including Bcl-2 family proteins and caspases.
- GA shows promise as a potential anticancer compound for melanoma, warranting further in vivo investigation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Caspases
Cellular Injury V: Apoptosis and Autophagy
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.